Skip to content

Flatiron Health at ASCO 2023. Learn more.

Flatiron Assist™

Our oncology-specific clinical decision support tool prioritizes evidence-based medicine, innovative treatment options, and clinical research at the point of care.

Stay ahead of innovative treatment options

Flatiron Assist™ elevates clinical care by arming clinicians with innovative treatment insights at the point of care via an EHR-integrated, intuitive decision-support tool. 

With instinctive workflows, up-to-date treatment guidelines, and actionable data, Flatiron Assist™ helps cancer centers and community oncologists improve the patient experience, streamline operations, and increase revenue.


Surface the latest oncology clinical pathways at the point of care

Updated NCCN® content

Flatiron Assist™ surfaces NCCN® Guidelines for 24 diseases, covering 90% of orders. Guidelines are continually updated within Flatiron Assist™ to ensure access to the latest information, including new biomarkers to help identify the best precision cancer treatments.

Customizable content
In addition to NCCN® content, Flatiron Assist™ allows you to create custom treatment pathways and regimens to meet cancer center or payer preferences.
Clinical trial opportunities

Flatiron Assist™ captures clinical trial data and surfaces it at the point of care based on patient clinical factors, helping clinicians easily identify research opportunities.

Streamlined prior authorization

Reduce the burden on administrative staff by capturing the data needed for prior authorization documentation in an easy-to-use structured format.

Enhanced data and reporting

Measure and analyze concordance, pathways compliance, clinician adoption, and care pattern variations at the clinician and location level.

Flatiron Assist™ in action

Flatiron Assist - Prior Auth
Flatiron Assist - Preferred Regimens Breast Cancer
Flatiron Assist - Regimen Selection Breast Cancer

By the numbers

Overall NCCN® concordance
Clinician adoption after one year

Updates of NCCN® guidelines in 2022

Reduction in denial rate
2 day
Improvement in time to prior authorization
Reduction in unique regimens ordered

The nice thing about Flatiron Assist™ is that you can get right where you want to go—and get there quickly—without having to dig through an algorithm.

Sylvia Richey, MD Associate Medical Director, West Cancer Center

How Flatiron Assist™ elevates clinical care

For clinicians For hospitals, health systems, and practices
Quickly find and order the right treatments through a seamless EHR-embedded workflow.

Reduce the amount of time patients have to wait between diagnosis and treatment.

Speed up prior authorizations and reduce denials.
Stay up-to-date on evolving treatment guidelines with the latest NCCN® guidance.
Easily identify clinical trial opportunities for your patients based on clinical factors.
Use biomarker data to select the best targeted therapy for patients.
Keep clinicians on top of evolving treatment guidelines by surfacing innovative treatment options at the point of care.

Standardize care by prioritizing preferred regimens and reducing the number of unique regimens ordered and maintained. 

Increase clinical trial enrollment by surfacing relevant trials alongside treatment options.
Use treatment pattern data to enable more efficient ordering of drugs and improve financial performance.
Provide a better patient experience by decreasing the time between diagnosis and treatment.
Leverage NCCN® and payer-preferred concordance data to excel in value-based care programs and strategic payer negotiations.
Expedite prior authorization approval by capturing concordance and other payer-required data elements.

Explore our clinical research product suite

Our clinical research product portfolio reduces burden through technology-supported trials and operational efficiencies, lowers costs and accelerates drug delivery to a diverse patient population, and supports teams from trial design up to FDA submission. 

Pattern C - Color Palette 3

Get in touch

Learn how Flatiron Assist™ supports clinical decisions in oncology.